Trial Profile
18F-AV-1451 PET Imaging in Subjects With Subacute Traumatic Brain Injury
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Traumatic brain injuries
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 04 Feb 2016 Status changed from not yet recruiting to withdrawn prior to enrolment, according to ClinicalTrials.gov record.
- 05 Aug 2015 New trial record